Blockade of interleukin-23 signaling results in targeted protection of the colon and allows for separation of graft-versus-host and graft-versus-leukemia responses.
Allogeneic stem cell transplantation is the most potent form of effective adoptive immunotherapy. The graft-versus-leukemia (GVL) effect mediated by the allogeneic graft, however, is typically coexpressed with graft-versus-host disease (GVHD), which is the major complication of allogeneic stem cell transplantation. In this study, we used genetic and antibody-based strategies to examine the effect that blockade of interleukin 23 (IL-23) signaling had on GVH and GVL reactivity in murine transplantation recipients. These studies demonstrate that the selective protection of the colon that occurs as a consequence of inhibition of IL-23 signaling reduces GVHD without loss of the GVL effect. The separation of GVH and GVL reactivity was noted in both acute and chronic hematologic malignancy models, indicating that this approach was not restricted by the kinetic profile of the underlying leukemia. Furthermore, a potent GVL response could be mounted in the colon under conditions where tumor cells migrated to this site, indicating that this organ did not serve as a sanctuary site for subsequent systemic relapse in GVHD-protected animals. These studies demonstrate that blockade of IL-23 signaling is an effective strategy for separating GVH and GVL responses and identify IL-23 as a therapeutic target for the regulation of alloresponses in humans.
Das
Rupali
R
Bone Marrow Transplant Program, Milwaukee, WI 53226, USA.
Komorowski
Richard
R
Hessner
Martin J
MJ
Subramanian
Hariharan
H
Huettner
Claudia S
CS
Cua
Daniel
D
Drobyski
William R
WR
D000208:Acute Disease; D000818:Animals; D002908:Chronic Disease; D003106:Colon / Q000276:immunology / Q000473:pathology; D003108:Colonic Diseases / Q000235:genetics / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*; D004195:Disease Models, Animal; D006086:Graft vs Host Disease / Q000235:genetics / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*; D020544:Graft vs Leukemia Effect / Q000235:genetics / Q000276:immunology*; D006801:Humans; D053760:Interleukin-23 Subunit p19; D007938:Leukemia / Q000235:genetics / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D051379:Mice; D008807:Mice, Inbred BALB C; D018345:Mice, Knockout; D015398:Signal Transduction / Q000235:genetics / Q000276:immunology; D033581:Stem Cell Transplantation; D014184:Transplantation, Homologous
C508841:Il23a protein, mouse; D053760:Interleukin-23 Subunit p19
Bone Marrow Transplant. 1998 Aug;22(3):259-64
9720739
Blood. 1997 Oct 15;90(8):3204-13
9376604
Leukemia. 2004 Nov;18(11):1789-97
15385924
J Immunol. 2007 Jun 15;178(12):7571-80
17548592
J Clin Invest. 2006 May;116(5):1317-26
16670771
J Exp Med. 1992 Feb 1;175(2):405-13
1732411
Biol Blood Marrow Transplant. 2007 Sep;13(9):1083-94
17697971
Blood. 2009 Jul 2;114(1):7-19
19336756
Bone Marrow Transplant. 2004 Dec;34(12):1057-65
15516937
Blood. 1990 Feb 1;75(3):555-62
2297567
J Endotoxin Res. 2002;8(6):441-8
12697087
Ann Intern Med. 1988 Jun;108(6):806-14
3285744
Blood. 2005 Jan 1;105(1):324-34
15331442
Nature. 2006 Jul 27;442(7101):461-5
16688182
J Exp Med. 2006 Oct 30;203(11):2485-94
17030948
Immunity. 2006 Aug;25(2):309-18
16919486
J Clin Invest. 2006 May;116(5):1310-6
16670770
Cancer Cell. 2009 Feb 3;15(2):114-23
19185846
Bone Marrow Transplant. 2006 Aug;38(4):305-10
16819438
Leukemia. 2006 May;20(5):793-9
16541140
Immunity. 2000 Nov;13(5):715-25
11114383
J Clin Invest. 2001 Jun;107(12):1581-9
11413166
Trends Immunol. 2007 May;28(5):207-12
17395538
Blood. 2009 Mar 5;113(10):2352-62
19059877
Cancer. 1999 Feb 1;85(3):608-15
10091734
J Immunol. 2000 Dec 1;165(11):6612-9
11086106
J Immunol. 2004 Mar 1;172(5):2827-33
14978083
J Immunol. 2006 May 1;176(9):5213-22
16621986
J Exp Med. 2006 Oct 30;203(11):2473-83
17030949
Bone Marrow Transplant. 2000 Nov;26(9):1011-5
11100282
Blood. 2003 Jan 15;101(2):766-70
12393700
Nucleic Acids Res. 2001 May 1;29(9):e45
11328886
Blood. 1993 Oct 15;82(8):2310-8
8400284
Nature. 1979 Oct 11;281(5731):490-1
386133
Leukemia. 1999 Sep;13(9):1383-9
10482989
N Engl J Med. 1981 Jun 18;304(25):1529-33
7015133
Blood. 1995 May 1;85(9):2632-8
7727789
Blood. 1989 May 1;73(6):1720-8
2653460
Blood. 2004 May 1;103(9):3590-8
14715632
Biol Blood Marrow Transplant. 1995 Dec;1(2):61-8
9118293